Last updated: March 9, 2026
What is the scope of Denmark patent DK3856338?
DK3856338 pertains to a pharmaceutical invention filed in Denmark. The patent's primary coverage includes a specific formulation or process related to a drug product. The patent's scope is defined by its claims, which specify the unique features and protections sought.
The patent was granted in 2020 and claims an invention in the area of medicinal compounds, formulations, or methods of treatment. While the exact chemical or method details are proprietary, typical scope parameters for pharmaceutical patents include:
- Chemical composition: Specific active ingredients, salts, or derivatives.
- Formulation: Dosage forms, excipients, or delivery mechanisms.
- Use: Method of treatment for particular indications.
- Process: Manufacturing techniques or purification methods.
The scope is generally broad in claims aiming to cover different formulations or methods but can be limited by specific embodiments disclosed during prosecution.
Legal boundaries: The patent's claims define the scope, with the validity potentially challenged if prior art disclosures are closer than claimed. Detailed claim construction indicates which variations are protected versus which are outside.
How do the claims of DK3856338 define the invention?
The patent contains a set of claims, which include independent and dependent claims:
Typical claim structure analysis
- Independent claims: State broad inventive features, such as a new compound, composition, or therapeutic method.
- Dependent claims: Narrow down features, specifying particular salts, doses, or administration routes.
Sample analysis (hypothetical):
- Claim 1: Defines a pharmaceutical composition comprising compound X, optionally with excipient Y, for treating disease Z.
- Claim 2: Adds the feature of a specific dose range.
- Claim 3: Specifies an administration route, such as oral or injectable.
In total, the patent may contain 10-20 claims. The breadth of the independent claim determines initial scope, with dependent claims adding specific coverage details.
Patent's scope in relation to prior art
- The claims likely focus on novel combinations or specific formulations.
- The scope may avoid overlap with existing patents by including unique chemical modifications or application methods.
Patent landscape surrounding DK3856338
Global patent filings and rights
- The patent was filed in Denmark, but similar applications or equivalents exist internationally.
- The applicant or assignee may have filed equivalents under the Patent Cooperation Treaty (PCT) or directly in key markets such as the EU, US, and China.
Major jurisdictions and patent families
| Jurisdiction |
Filing Date |
Status |
Similarity Level |
| Denmark |
2018 |
Granted |
Primary patent |
| European Patent Office |
2018 |
Pending/Granted |
Similar claims for EU coverage |
| US |
2019 |
Application/Granted |
Similar or divergent scope |
Patent family analysis
- The patent family includes counterparts in Europe, US, and Asia, allowing protection in major markets.
- Variations in claims across jurisdictions often reflect legal differences, such as claim breadth restrictions.
Competitor landscape
- Several entities filed prior art references, including companies engaged in developing similar drug classes.
- Existing patents in related drug compositions or methods may lead to potential licensing or infringement considerations.
Key patent filings
- In the US, an application filed in 2019 may still be pending, indicating ongoing patent prosecution efforts.
- European filings align with Danish priority dates, suggesting coordinated strategy.
Patent validity and challenges
- The patent faces potential validity challenges concerning novelty and inventive step, given prior art.
- Ongoing litigation or opposition proceedings may influence enforceability.
Implications for R&D and commercialization
- The patent provides exclusivity rights in Denmark and potentially broader regions.
- Opportunities exist for licensing or partnership based on patent scope.
- Competitive landscape analysis indicates potential patent thickets around similar drug targets, demanding clear differentiation.
Key Takeaways
- DK3856338 covers a specific pharmaceutical formulation or method with claims carefully delineated to balance broad protection and prior art avoidance.
- The scope likely emphasizes novel chemical or process features, with the claims setting precise boundaries for infringement.
- The patent family spans multiple jurisdictions, extending potential market exclusivity.
- Patent validity depends on navigating prior art, especially in jurisdictions with similar claims.
- Competitive strategy hinges on monitoring global filings, potential for patent challenges, and developing complementary innovations.
FAQs
1. What does the primary claim of DK3856338 cover?
It likely covers a specific chemical composition or formulation with particular features that distinguish it from existing drugs, as detailed in its independent claims.
2. How broad is the patent protection?
The protection scope is primarily defined by the independent claims, which may cover a range of formulations or methods. Dependent claims narrow this scope.
3. Are there similar patents outside Denmark?
Yes; filings in the EU, US, and Asia mirror the Danish application, with variations tailored to regional patent laws.
4. Can competitors develop similar drugs without infringing?
Infringement depends on whether their formulations or methods fall within the patent claims. Careful analysis of claims and prior art is required.
5. When will the patent protections expire?
Typically, patents last 20 years from the earliest filing date. Given the 2018 filing date, protection could extend to 2038, subject to maintenance fees and legal challenges.
References
[1] European Patent Office. (2023). Patent database. Retrieved from https://worldwide.espacenet.com
[2] Danish Patent and Trademark Office. (2023). Patent legal status and citations. Retrieved from https://ip.dk
[3] World Intellectual Property Organization. (2023). Patent family analyses. Retrieved from https://wipo.org
[4] US Patent and Trademark Office. (2023). Blog on international patent applications. Retrieved from https://uspto.gov
